Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 105 entries
Sorted by: Best Match Show Resources per page
Interphase tuning for stronger and tougher composites.

Scientific reports

Livanov K, Yang L, Nissenbaum A, Wagner HD.
PMID: 27230418
Sci Rep. 2016 May 27;6:26305. doi: 10.1038/srep26305.

The development of composite materials that are simultaneously strong and tough is one of the most active topics of current material science. Observations of biological structural materials show that adequate introduction of reinforcements and interfaces, or interphases, at different...

Cite
Livanov K, Yang L, Nissenbaum A, et al. Interphase tuning for stronger and tougher composites. Sci Rep. 2016;6:26305doi: 10.1038/srep26305.
Livanov, K., Yang, L., Nissenbaum, A., & Wagner, H. D. (2016). Interphase tuning for stronger and tougher composites. Scientific reports, 626305. https://doi.org/10.1038/srep26305
Livanov, Konstantin, et al. "Interphase tuning for stronger and tougher composites." Scientific reports vol. 6 (2016): 26305. doi: https://doi.org/10.1038/srep26305
Livanov K, Yang L, Nissenbaum A, Wagner HD. Interphase tuning for stronger and tougher composites. Sci Rep. 2016 May 27;6:26305. doi: 10.1038/srep26305. PMID: 27230418; PMCID: PMC4882545.
Copy Download .nbib Format: NLM
The microbiology and biogeochemistry of the Dead Sea.

Microbial ecology

Nissenbaum A.
PMID: 24241235
Microb Ecol. 1975 Jun;2(2):139-61. doi: 10.1007/BF02010435.

The Dead Sea is a hypersaline water body. Its total dissolved salts content is on the average 322.6 gm/liter. The dominant cation is Mg (40.7 gm/liter), followed by Na (39.2 gm/liter), Ca (17 gm/liter) and K (7 gm/liter). The...

Cite
Nissenbaum A. The microbiology and biogeochemistry of the Dead Sea. Microb Ecol. 1975;2(2):139-61doi: 10.1007/BF02010435.
Nissenbaum, A. (1975). The microbiology and biogeochemistry of the Dead Sea. Microbial ecology, 2(2), 139-61. https://doi.org/10.1007/BF02010435
Nissenbaum, A. "The microbiology and biogeochemistry of the Dead Sea." Microbial ecology vol. 2,2 (1975): 139-61. doi: https://doi.org/10.1007/BF02010435
Nissenbaum A. The microbiology and biogeochemistry of the Dead Sea. Microb Ecol. 1975 Jun;2(2):139-61. doi: 10.1007/BF02010435. PMID: 24241235.
Copy Download .nbib Format: NLM
Toppling the Tower of Babel. Isn't it about time we achieved true interoperability?.

Health management technology

Nissenbaum M.
PMID: 27443083
Health Manag Technol. 2016 Jun;37(4):32.

No abstract available.

Cite
Nissenbaum M. Toppling the Tower of Babel. Isn't it about time we achieved true interoperability?. Health Manag Technol. 2016;37(4):32
Nissenbaum, M. (2016). Toppling the Tower of Babel. Isn't it about time we achieved true interoperability?. Health management technology, 37(4), 32.
Nissenbaum, Michael. "Toppling the Tower of Babel. Isn't it about time we achieved true interoperability?." Health management technology vol. 37,4 (2016): 32.
Nissenbaum M. Toppling the Tower of Babel. Isn't it about time we achieved true interoperability?. Health Manag Technol. 2016 Jun;37(4):32. PMID: 27443083.
Copy Download .nbib Format: NLM
Living unlabeled--diagnosis and disorder.

The New England journal of medicine

Rosenbaum L.
PMID: 18923169
N Engl J Med. 2008 Oct 16;359(16):1650-3. doi: 10.1056/NEJMp0804984.

No abstract available.

Cite
Rosenbaum L. Living unlabeled--diagnosis and disorder. N Engl J Med. 2008;359(16):1650-3doi: 10.1056/NEJMp0804984.
Rosenbaum, L. (2008). Living unlabeled--diagnosis and disorder. The New England journal of medicine, 359(16), 1650-3. https://doi.org/10.1056/NEJMp0804984
Rosenbaum, Lisa. "Living unlabeled--diagnosis and disorder." The New England journal of medicine vol. 359,16 (2008): 1650-3. doi: https://doi.org/10.1056/NEJMp0804984
Rosenbaum L. Living unlabeled--diagnosis and disorder. N Engl J Med. 2008 Oct 16;359(16):1650-3. doi: 10.1056/NEJMp0804984. PMID: 18923169.
Copy Download .nbib Format: NLM
Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature.

Journal of hematopathology

Rosenbaum L, Fekrazad MH, Rabinowitz I, Vasef MA.
PMID: 19669195
J Hematop. 2009 Jul;2(2):127-31. doi: 10.1007/s12308-009-0030-3. Epub 2009 Mar 31.

We report two rare examples of Epstein-Barr virus (EBV)-associated inflammatory pseudotumor of the spleen. One patient presented with night sweats, abdominal pain, and weight loss and was found to have a splenic mass on CT scan suspected of lymphoma....

Cite
Rosenbaum L, Fekrazad MH, Rabinowitz I, et al. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop. 2009;2(2):127-31doi: 10.1007/s12308-009-0030-3.
Rosenbaum, L., Fekrazad, M. H., Rabinowitz, I., & Vasef, M. A. (2009). Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. Journal of hematopathology, 2(2), 127-31. https://doi.org/10.1007/s12308-009-0030-3
Rosenbaum, Lizabeth, et al. "Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature." Journal of hematopathology vol. 2,2 (2009): 127-31. doi: https://doi.org/10.1007/s12308-009-0030-3
Rosenbaum L, Fekrazad MH, Rabinowitz I, Vasef MA. Epstein-Barr virus-associated inflammatory pseudotumor of the spleen: report of two cases and review of the literature. J Hematop. 2009 Jul;2(2):127-31. doi: 10.1007/s12308-009-0030-3. Epub 2009 Mar 31. PMID: 19669195; PMCID: PMC2725282.
Copy Download .nbib Format: NLM
Photomultiplier single photon counting efficiency.

Applied optics

Birenbaum L, Scarl DB.
PMID: 20125337
Appl Opt. 1973 Mar 01;12(3):519-21. doi: 10.1364/AO.12.000519.

An RCA C31000F (8853) photomultiplier with a cathode quantum efficiency of 5.5% (for 633-nm light) was found to have a single photon counting efficiency of only 3.3%. The difference is shown to be due to small pulses well below...

Cite
Birenbaum L, Scarl DB. Photomultiplier single photon counting efficiency. Appl Opt. 1973;12(3):519-21doi: 10.1364/AO.12.000519.
Birenbaum, L., & Scarl, D. B. (1973). Photomultiplier single photon counting efficiency. Applied optics, 12(3), 519-21. https://doi.org/10.1364/AO.12.000519
Birenbaum, L, and Scarl, D B. "Photomultiplier single photon counting efficiency." Applied optics vol. 12,3 (1973): 519-21. doi: https://doi.org/10.1364/AO.12.000519
Birenbaum L, Scarl DB. Photomultiplier single photon counting efficiency. Appl Opt. 1973 Mar 01;12(3):519-21. doi: 10.1364/AO.12.000519. PMID: 20125337.
Copy Download .nbib Format: NLM
Energies of the adsorption of functional groups to calcium carbonate polymorphs: the importance of -OH and -COOH groups.

Langmuir : the ACS journal of surfaces and colloids

Okhrimenko DV, Nissenbaum J, Andersson MP, Olsson MH, Stipp SL.
PMID: 23919655
Langmuir. 2013 Sep 03;29(35):11062-73. doi: 10.1021/la402305x. Epub 2013 Aug 21.

The adsorption behavior of calcium carbonate is an important factor in many processes in nature, industry, and biological systems. We determined and compared the adsorption energies for a series of small molecules of different sizes and polarities (i.e., water,...

Cite
Okhrimenko DV, Nissenbaum J, Andersson MP, et al. Energies of the adsorption of functional groups to calcium carbonate polymorphs: the importance of -OH and -COOH groups. Langmuir. 2013;29(35):11062-73doi: 10.1021/la402305x.
Okhrimenko, D. V., Nissenbaum, J., Andersson, M. P., Olsson, M. H., & Stipp, S. L. (2013). Energies of the adsorption of functional groups to calcium carbonate polymorphs: the importance of -OH and -COOH groups. Langmuir : the ACS journal of surfaces and colloids, 29(35), 11062-73. https://doi.org/10.1021/la402305x
Okhrimenko, D V, et al. "Energies of the adsorption of functional groups to calcium carbonate polymorphs: the importance of -OH and -COOH groups." Langmuir : the ACS journal of surfaces and colloids vol. 29,35 (2013): 11062-73. doi: https://doi.org/10.1021/la402305x
Okhrimenko DV, Nissenbaum J, Andersson MP, Olsson MH, Stipp SL. Energies of the adsorption of functional groups to calcium carbonate polymorphs: the importance of -OH and -COOH groups. Langmuir. 2013 Sep 03;29(35):11062-73. doi: 10.1021/la402305x. Epub 2013 Aug 21. PMID: 23919655.
Copy Download .nbib Format: NLM
Normal Cerebral Oxygen Consumption Despite Elevated Cerebral Blood Flow in Adolescents With Bipolar Disorder: Putative Neuroimaging Evidence of Anomalous Energy Metabolism.

Frontiers in psychiatry

Karthikeyan S, Fiksenbaum L, Grigorian A, Lu H, MacIntosh BJ, Goldstein BI.
PMID: 31681045
Front Psychiatry. 2019 Oct 11;10:739. doi: 10.3389/fpsyt.2019.00739. eCollection 2019.

No abstract available.

Cite
Karthikeyan S, Fiksenbaum L, Grigorian A, et al. Normal Cerebral Oxygen Consumption Despite Elevated Cerebral Blood Flow in Adolescents With Bipolar Disorder: Putative Neuroimaging Evidence of Anomalous Energy Metabolism. Front Psychiatry. 2019;10:739doi: 10.3389/fpsyt.2019.00739.
Karthikeyan, S., Fiksenbaum, L., Grigorian, A., Lu, H., MacIntosh, B. J., & Goldstein, B. I. (2019). Normal Cerebral Oxygen Consumption Despite Elevated Cerebral Blood Flow in Adolescents With Bipolar Disorder: Putative Neuroimaging Evidence of Anomalous Energy Metabolism. Frontiers in psychiatry, 10739. https://doi.org/10.3389/fpsyt.2019.00739
Karthikeyan, Sudhir, et al. "Normal Cerebral Oxygen Consumption Despite Elevated Cerebral Blood Flow in Adolescents With Bipolar Disorder: Putative Neuroimaging Evidence of Anomalous Energy Metabolism." Frontiers in psychiatry vol. 10 (2019): 739. doi: https://doi.org/10.3389/fpsyt.2019.00739
Karthikeyan S, Fiksenbaum L, Grigorian A, Lu H, MacIntosh BJ, Goldstein BI. Normal Cerebral Oxygen Consumption Despite Elevated Cerebral Blood Flow in Adolescents With Bipolar Disorder: Putative Neuroimaging Evidence of Anomalous Energy Metabolism. Front Psychiatry. 2019 Oct 11;10:739. doi: 10.3389/fpsyt.2019.00739. eCollection 2019. PMID: 31681045; PMCID: PMC6798187.
Copy Download .nbib Format: NLM
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.

Frontiers in aging neuroscience

Ojo JO, Reed JM, Crynen G, Vallabhaneni P, Evans J, Shackleton B, Eisenbaum M, Ringland C, Edsell A, Mullan M, Crawford F, Bachmeier C.
PMID: 34079449
Front Aging Neurosci. 2021 May 17;13:658605. doi: 10.3389/fnagi.2021.658605. eCollection 2021.

Cerebrovascular dysfunction and cerebral amyloid angiopathy (CAA) are hallmark features of Alzheimer's disease (AD). Molecular damage to cerebrovessels in AD may result in alterations in vascular clearance mechanisms leading to amyloid deposition around blood vessels and diminished neurovascular-coupling. The...

Cite
Ojo JO, Reed JM, Crynen G, et al. Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy. Front Aging Neurosci. 2021;13:658605doi: 10.3389/fnagi.2021.658605.
Ojo, J. O., Reed, J. M., Crynen, G., Vallabhaneni, P., Evans, J., Shackleton, B., Eisenbaum, M., Ringland, C., Edsell, A., Mullan, M., Crawford, F., & Bachmeier, C. (2021). Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy. Frontiers in aging neuroscience, 13658605. https://doi.org/10.3389/fnagi.2021.658605
Ojo, Joseph O, et al. "Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy." Frontiers in aging neuroscience vol. 13 (2021): 658605. doi: https://doi.org/10.3389/fnagi.2021.658605
Ojo JO, Reed JM, Crynen G, Vallabhaneni P, Evans J, Shackleton B, Eisenbaum M, Ringland C, Edsell A, Mullan M, Crawford F, Bachmeier C. Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy. Front Aging Neurosci. 2021 May 17;13:658605. doi: 10.3389/fnagi.2021.658605. eCollection 2021. PMID: 34079449; PMCID: PMC8166206.
Copy Download .nbib Format: NLM
Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study.

Brain, behavior, and immunity

Karthikeyan S, Dimick MK, Fiksenbaum L, Jeong H, Birmaher B, Kennedy JL, Lanctôt K, Levitt AJ, Miller GE, Schaffer A, Young LT, Youngstrom EA, Andreazza AC, Goldstein BI.
PMID: 34896179
Brain Behav Immun. 2021 Dec 08;100:278-286. doi: 10.1016/j.bbi.2021.11.020. Epub 2021 Dec 08.

BACKGROUND: Numerous studies have found elevated pro-inflammatory markers and reduced brain-derived neurotrophic factor (BDNF) during symptomatic episodes of bipolar disorder (BD) in adults. There is a paucity of research examining these markers in youth with BD, or longitudinally in...

Cite
Karthikeyan S, Dimick MK, Fiksenbaum L, et al. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain Behav Immun. 2021;100:278-286doi: 10.1016/j.bbi.2021.11.020.
Karthikeyan, S., Dimick, M. K., Fiksenbaum, L., Jeong, H., Birmaher, B., Kennedy, J. L., Lanctôt, K., Levitt, A. J., Miller, G. E., Schaffer, A., Young, L. T., Youngstrom, E. A., Andreazza, A. C., & Goldstein, B. I. (2021). Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain, behavior, and immunity, 100278-286. https://doi.org/10.1016/j.bbi.2021.11.020
Karthikeyan, Sudhir, et al. "Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study." Brain, behavior, and immunity vol. 100 (2021): 278-286. doi: https://doi.org/10.1016/j.bbi.2021.11.020
Karthikeyan S, Dimick MK, Fiksenbaum L, Jeong H, Birmaher B, Kennedy JL, Lanctôt K, Levitt AJ, Miller GE, Schaffer A, Young LT, Youngstrom EA, Andreazza AC, Goldstein BI. Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study. Brain Behav Immun. 2021 Dec 08;100:278-286. doi: 10.1016/j.bbi.2021.11.020. Epub 2021 Dec 08. PMID: 34896179.
Copy Download .nbib Format: NLM
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.

NPJ breast cancer

Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB.
PMID: 31728408
NPJ Breast Cancer. 2019 Nov 08;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019.

The 21-gene Recurrence Score (RS) assay is a validated prognosticator/predictor of chemotherapy (CT) benefit in early-stage estrogen receptor (ER)-positive breast cancer (BC). Long-term data from real-life clinical practice where treatment was guided by the RS result are lacking. We...

Cite
Stemmer SM, Steiner M, Rizel S, et al. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019;5:41doi: 10.1038/s41523-019-0137-3.
Stemmer, S. M., Steiner, M., Rizel, S., Ben-Baruch, N., Uziely, B., Jakubowski, D. M., Baron, J., Shak, S., Soussan-Gutman, L., Bareket-Samish, A., Fried, G., Rosengarten, O., Itay, A., Nisenbaum, B., Katz, D., Leviov, M., Tokar, M., Liebermann, N., & Geffen, D. B. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ breast cancer, 541. https://doi.org/10.1038/s41523-019-0137-3
Stemmer, Salomon M, et al. "Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy." NPJ breast cancer vol. 5 (2019): 41. doi: https://doi.org/10.1038/s41523-019-0137-3
Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019 Nov 08;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019. PMID: 31728408; PMCID: PMC6841708.
Copy Download .nbib Format: NLM
Pediatric primary care in Ontario and Manitoba after the onset of the COVID-19 pandemic: a population-based study.

CMAJ open

Saunders N, Guttmann A, Brownell M, Cohen E, Fu L, Guan J, Sarkar J, Mahar A, Gandhi S, Fiksenbaum L, Katz A, Eze N, Stukel TA.
PMID: 34906990
CMAJ Open. 2021 Dec 14;9(4):E1149-E1158. doi: 10.9778/cmajo.20210161. Print 2021.

BACKGROUND: There were large disruptions to health care services after the onset of the COVID-19 pandemic. We sought to describe the extent to which pandemic-related changes in service delivery and access affected use of primary care for children overall...

Cite
Saunders N, Guttmann A, Brownell M, et al. Pediatric primary care in Ontario and Manitoba after the onset of the COVID-19 pandemic: a population-based study. CMAJ Open. 2021;9(4):E1149-E1158doi: 10.9778/cmajo.20210161.
Saunders, N., Guttmann, A., Brownell, M., Cohen, E., Fu, L., Guan, J., Sarkar, J., Mahar, A., Gandhi, S., Fiksenbaum, L., Katz, A., Eze, N., & Stukel, T. A. (2021). Pediatric primary care in Ontario and Manitoba after the onset of the COVID-19 pandemic: a population-based study. CMAJ open, 9(4), E1149-E1158. https://doi.org/10.9778/cmajo.20210161
Saunders, Natasha, et al. "Pediatric primary care in Ontario and Manitoba after the onset of the COVID-19 pandemic: a population-based study." CMAJ open vol. 9,4 (2021): E1149-E1158. doi: https://doi.org/10.9778/cmajo.20210161
Saunders N, Guttmann A, Brownell M, Cohen E, Fu L, Guan J, Sarkar J, Mahar A, Gandhi S, Fiksenbaum L, Katz A, Eze N, Stukel TA. Pediatric primary care in Ontario and Manitoba after the onset of the COVID-19 pandemic: a population-based study. CMAJ Open. 2021 Dec 14;9(4):E1149-E1158. doi: 10.9778/cmajo.20210161. Print 2021. PMID: 34906990.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 105 entries